You are here

AbbVie

AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again

Fierce Pharma

Fri, 04/26/24 - 11:18 am

atopic dermatitis

AbbVie lifts profit forecast after Skyrizi sales beat expectations

Reuters

Fri, 04/26/24 - 11:12 am

Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost

BioSpace

Fri, 04/26/24 - 11:09 am

Evernorth Health

Emergence of ADCs as the “hot, new technology”

Pharmaphorum

Thu, 04/25/24 - 11:39 am

antibody-drug conjugate

AbbVie and Regenxbio’s ‘multibillion-dollar opportunity’ in vision loss gene therapy

Pharma Voice

Wed, 04/24/24 - 08:42 am

wet age-related macular degeneration

diabetic retinopathy

AbbVie tops doctor ranking of immunology companies, handily beating Pfizer and J&J

BioSpace

Mon, 04/22/24 - 11:45 am

AbbVie, NeuroDerm Heat Up Levodopa Competition with New Data at AAN24

BioSpace

Mon, 04/22/24 - 11:40 am

Parkinson's Disease

Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US

BioSpace

Fri, 04/19/24 - 11:28 am

Teva Pharmaceutical

AbbVie touts Rinvoq win in giant cell arteritis, potentially teeing up another label expansion

Fierce Pharma

Thu, 04/18/24 - 11:15 am

clinical trials

giant cell arteritis

Humira biosimilar scripts take off

Axios

Tue, 04/16/24 - 07:42 am

AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment

BioSpace

Mon, 04/15/24 - 11:06 am

clinical trials

Rinvoq reclaims top Rx, OTC pharma brand crown

Medical Marketing and Media

Sun, 04/14/24 - 01:29 pm

OTC advertising

AbbVie-backed effort spotlights night symptoms of Parkinson’s

Medical Marketing and Media

Thu, 04/11/24 - 10:15 pm

Parkinson's Disease

public awareness

7 Billion-Dollar Oncology M&As from Q1

BioSpace

Wed, 04/10/24 - 11:24 am

Bristol Myers Squibb

Mirati Therapeutics

Fusion Pharmaceuticals

AbbVie’s Humira Loses Only 4% of Market Share to Biosimilars: Report

BioSpace

Tue, 04/9/24 - 11:15 am

For biopharma M&A, the best returns come from small deals: analysts

Fierce Pharma

Tue, 04/9/24 - 11:14 am

Bristol Myers Squibb

Why AbbVie is making big bets on telling the story of its R&D investments

Medical Marketing and Media

Mon, 04/8/24 - 11:56 am

Boehringer to lay off salespeople as Humira biosimilar sales lag

Reuters

Fri, 04/5/24 - 11:33 am

Boehringer Ingelheim

Genmab expands US headquarters, plots 300 hires amid launch of AbbVie-partnered lymphoma med Epkinly

Fierce Pharma

Thu, 03/28/24 - 04:59 pm

AbbVie to bolster immunity illness drug pipeline with Landos buy

Yahoo/Reuters

Mon, 03/25/24 - 11:39 am

Landos Biopharma

immune disorders

Pages